<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27509858</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>09</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-4687</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>536</Volume>
            <Issue>7617</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Aug</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nature</Title>
          <ISOAbbreviation>Nature</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.</ArticleTitle>
        <Pagination>
          <StartPage>479</StartPage>
          <EndPage>483</EndPage>
          <MedlinePgn>479-83</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nature19084</ELocationID>
        <Abstract>
          <AbstractText>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease characterized by an intense fibrotic stromal response and deregulated metabolism. The role of the stroma in PDAC biology is complex and it has been shown to play critical roles that differ depending on the biological context. The stromal reaction also impairs the vasculature, leading to a highly hypoxic, nutrient-poor environment. As such, these tumours must alter how they capture and use nutrients to support their metabolic needs. Here we show that stroma-associated pancreatic stellate cells (PSCs) are critical for PDAC metabolism through the secretion of non-essential amino acids (NEAA). Specifically, we uncover a previously undescribed role for alanine, which outcompetes glucose and glutamine-derived carbon in PDAC to fuel the tricarboxylic acid (TCA) cycle, and thus NEAA and lipid biosynthesis. This shift in fuel source decreases the tumour’s dependence on glucose and serum-derived nutrients, which are limited in the pancreatic tumour microenvironment. Moreover, we demonstrate that alanine secretion by PSCs is dependent on PSC autophagy, a process that is stimulated by cancer cells. Thus, our results demonstrate a novel metabolic interaction between PSCs and cancer cells, in which PSC-derived alanine acts as an alternative carbon source. This finding highlights a previously unappreciated metabolic network within pancreatic tumours in which diverse fuel sources are used to promote growth in an austere tumour microenvironment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sousa</LastName>
            <ForeName>Cristovão M</ForeName>
            <Initials>CM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Biancur</LastName>
            <ForeName>Douglas E</ForeName>
            <Initials>DE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiaoxu</ForeName>
            <Initials>X</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Halbrook</LastName>
            <ForeName>Christopher J</ForeName>
            <Initials>CJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sherman</LastName>
            <ForeName>Mara H</ForeName>
            <Initials>MH</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kremer</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Rosa F</ForeName>
            <Initials>RF</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Witkiewicz</LastName>
            <ForeName>Agnes K</ForeName>
            <Initials>AK</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ying</LastName>
            <ForeName>Haoqiang</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Asara</LastName>
            <ForeName>John M</ForeName>
            <Initials>JM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Evans</LastName>
            <ForeName>Ronald M</ForeName>
            <Initials>RM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cantley</LastName>
            <ForeName>Lewis C</ForeName>
            <Initials>LC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lyssiotis</LastName>
            <ForeName>Costas A</ForeName>
            <Initials>CA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kimmelman</LastName>
            <ForeName>Alec C</ForeName>
            <Initials>AC</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>GM095567</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01CA188048</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 CA046592</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R00 CA188259</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01 CA117969</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01 CA120964</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA157490</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 GM095567</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01CA117969</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>DK097153</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01CA157490</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R37 DK057978</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>5P30CA06516</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA188048</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>S10 OD010612</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 CA006516</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Acronym>HHMI_</Acronym>
            <Agency>Howard Hughes Medical Institute</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 CA014195</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30CA006516</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 CA009370</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01CA120964</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U24 DK097153</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>08</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nature</MedlineTA>
        <NlmUniqueID>0410462</NlmUniqueID>
        <ISSNLinking>0028-0836</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>7440-44-0</RegistryNumber>
          <NameOfSubstance UI="D002244">Carbon</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>OF5P57N2ZX</RegistryNumber>
          <NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Nature. 2016 Aug 25;536(7617):401-2</RefSource>
          <PMID Version="1">27509862</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):558-9</RefSource>
          <PMID Version="1">27555474</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Nature. 2016 Dec 1;540(7631):150</RefSource>
          <PMID Version="1">27706144</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053898" MajorTopicYN="N">Biosynthetic Pathways</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002244" MajorTopicYN="N">Carbon</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021441" MajorTopicYN="N">Carcinoma, Pancreatic Ductal</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002952" MajorTopicYN="N">Citric Acid Cycle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064593" MajorTopicYN="N">Heterografts</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009368" MajorTopicYN="N">Neoplasm Transplantation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058954" MajorTopicYN="N">Pancreatic Stellate Cells</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059016" MajorTopicYN="N">Tumor Microenvironment</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare competing financial interests: details are available in the online version of the paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2015</Year>
          <Month>10</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2016</Year>
          <Month>7</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>8</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>8</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27509858</ArticleId>
        <ArticleId IdType="mid">HHMIMS817814</ArticleId>
        <ArticleId IdType="pmc">PMC5228623</ArticleId>
        <ArticleId IdType="doi">10.1038/nature19084</ArticleId>
        <ArticleId IdType="pii">nature19084</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–1617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20427809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sousa CM, Kimmelman AC. The complex landscape of pancreatic cancer metabolism. Carcinogenesis. 2014;35:1441–1450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4076815</ArticleId>
            <ArticleId IdType="pubmed">24743516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whatcott CJ, et al.  Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clin Cancer Res. 2015;21:3561–3568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4526394</ArticleId>
            <ArticleId IdType="pubmed">25695692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feig C, et al.  The pancreas cancer microenvironment. Clin Cancer Res. 2012;18:4266–4276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3442232</ArticleId>
            <ArticleId IdType="pubmed">22896693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erkan M, et al.  StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61:172–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3245897</ArticleId>
            <ArticleId IdType="pubmed">22115911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gore J, Korc M. Pancreatic cancer stroma: friend or foe? Cancer Cell. 2014;25:711–712.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4821630</ArticleId>
            <ArticleId IdType="pubmed">24937454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte MV, Wilson JS. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells. J Gastroenterol Hepatol. 2012;27(Suppl 2):69–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22320920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Özdemir BC, et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719–734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4180632</ArticleId>
            <ArticleId IdType="pubmed">24856586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhim AD, et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735–747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4096698</ArticleId>
            <ArticleId IdType="pubmed">24856585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feig C, et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci USA. 2013;110:20212–20217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3864274</ArticleId>
            <ArticleId IdType="pubmed">24277834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamphorst JJ, et al.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75:544–553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4316379</ArticleId>
            <ArticleId IdType="pubmed">25644265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olive KP, et al.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457–1461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2998180</ArticleId>
            <ArticleId IdType="pubmed">19460966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Commisso C, et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497:633–637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3810415</ArticleId>
            <ArticleId IdType="pubmed">23665962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Son J, et al.  Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496:101–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3656466</ArticleId>
            <ArticleId IdType="pubmed">23535601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying H, et al.  Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012;149:656–670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3472002</ArticleId>
            <ArticleId IdType="pubmed">22541435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang RF, et al.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918–926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2519173</ArticleId>
            <ArticleId IdType="pubmed">18245495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protocols. 2012;7:872–881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3685491</ArticleId>
            <ArticleId IdType="pubmed">22498707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang A, et al.  Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 2014;4:905–913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4125497</ArticleId>
            <ArticleId IdType="pubmed">24875860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S, et al.  Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011;25:717–729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3070934</ArticleId>
            <ArticleId IdType="pubmed">21406549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao H, et al.  Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife. 2016;5:e10250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4841778</ArticleId>
            <ArticleId IdType="pubmed">26920219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonveaux P, et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest. 2008;118:3930–3942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2582933</ArticleId>
            <ArticleId IdType="pubmed">19033663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tape CJ, et al.  Oncogenic KRAS regulates tumor cell signaling via stromal reciprocation. Cell. 2016;165:910–920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4868820</ArticleId>
            <ArticleId IdType="pubmed">27087446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serrao EM, et al.  MRI with hyperpolarised [1-13C] pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model. Gut. 2015  http://dx.doi.org/10.1136/gutjnl-2015-310114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2015-310114</ArticleId>
            <ArticleId IdType="pmc">PMC4789827</ArticleId>
            <ArticleId IdType="pubmed">26347531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trinquier G, Sanejouand YH. Which effective property of amino acids is best preserved by the genetic code? Protein Eng. 1998;11:153–169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9613840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherman MH, et al.  Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell. 2014;159:80–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4177038</ArticleId>
            <ArticleId IdType="pubmed">25259922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ouyang H, et al.  Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol. 2000;157:1623–1631.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1885733</ArticleId>
            <ArticleId IdType="pubmed">11073822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metallo CM, et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2012;481:380–384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3710581</ArticleId>
            <ArticleId IdType="pubmed">22101433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez CA, Des Rosiers C, Previs SF, David F, Brunengraber H. Correction of 13C mass isotopomer distributions for natural stable isotope abundance. J Mass Spectrom. 1996;31:255–262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8799277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sastra SA, Olive KP. Quantification of murine pancreatic tumors by high-resolution ultrasound. Methods Mol Biol. 2013;980:249–266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3879959</ArticleId>
            <ArticleId IdType="pubmed">23359158</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
